JLE

European Journal of Dermatology

MENU

Implementing therapeutic goals in maintenance treatment of psoriasis with biologics: adalimumab can be more cost-effective than infliximab or ustekinumab in real life Volume 23, issue 3, May-June 2013

Authors
Department of Dermatology, Hospital de la Santa Creu i Sant Pau,, Universitat Autònoma de Barcelona, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain

ejd.2013.2017 Auteur(s) : Lluís Puig1,2 lpuig@santpau.cat, Caridad-Elena Morales-Múnera1,2 1 Department of Dermatology, Hospital de la Santa Creu i Sant Pau, 2 Universitat Autònoma de Barcelona, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain Currently available biologics for the treatment of moderate to severe psoriasis are more effective than non-biologic therapeutic options, but much more expensive: the average cost in the maintenance phase of treatment at standard doses for the average weight [...]